跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
吉泰瑞 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Afatinib Dimaleate Tablets
Approved
化学药品
Afatinib Dimaleate Tablets
Boehringer Ingelheim International GmbH
🇨🇳 National Medical Products Administration
Approval Date
Jul 12, 2021
Approval ID
8BYsgn3EQYB
Company
Boehringer Ingelheim International GmbH
Type
化学药品
Approval Details
Approval Id
8BYsgn3EQYB
Approval Number
国药准字HJ20170068
Generic Name
马来酸阿法替尼片
Generic Name En
Afatinib Dimaleate Tablets
Trade Name
吉泰瑞
Drug Type
化学药品
Dosage Form
片剂
Strength
40mg(按C₂₄H₂₅ClFN₅O₃计)
Reg Date
2021-07-12
Expired Date
2026-07-11
Company Name
Boehringer Ingelheim International GmbH
Production Company Name
Boehringer Ingelheim Pharma GmbH & Co. KG
Company Detail Path
/organization/boehringer-ingelheim-international-gmbh
Production Company Detail Path
/organization/boehringer-ingelheim-pharma-gmbh-and-co-kg
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jul 12, 2021
Approval ID
8BYsgn3EQYB
Type
化学药品
Back to NMPA Approvals